| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology Group
|
Kirtek, Timothy
|
|
|
130 |
C |
p.
|
article
|
| 2 |
Acute myeloid leukemia in the medically unfit elderly patients
|
Edmund, Joseph
|
|
|
130 |
C |
p.
|
article
|
| 3 |
Alternating venetoclax/azacytidine and FLT3 inhibitor treatment for NPM1- and FLT3-mutated acute myeloid leukemia
|
Oya, Shuki
|
|
|
130 |
C |
p.
|
article
|
| 4 |
Comparison of a modified pediatric protocol versus a hyper-CVAD protocol in adolescents and young adults with Philadelphia-negative acute lymphoblastic leukemia: A multicenter retrospective analysis
|
Salama, Hind
|
|
|
130 |
C |
p.
|
article
|
| 5 |
Corrigendum to “Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines” [Leukemia Res. 128, 107054]
|
Illangeswaran, Raveen Stephen Stallon
|
|
|
130 |
C |
p.
|
article
|
| 6 |
CRIP1 supports the growth and migration of AML-M5 subtype cells by activating Wnt/β-catenin pathway
|
Deng, Xiaoling
|
|
|
130 |
C |
p.
|
article
|
| 7 |
Editorial Board
|
|
|
|
130 |
C |
p.
|
article
|
| 8 |
Enhancing morphological analysis of peripheral blood cells in chronic lymphocytic leukemia with an artificial intelligence-based tool
|
Wang, Yan
|
|
|
130 |
C |
p.
|
article
|
| 9 |
First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia
|
Balsat, Marie
|
|
|
130 |
C |
p.
|
article
|
| 10 |
Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia
|
Atchley, Evan
|
|
|
130 |
C |
p.
|
article
|
| 11 |
Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities
|
Younes, Ismail Elbaz
|
|
|
130 |
C |
p.
|
article
|
| 12 |
Specific immune response to mRNA vaccines against COVID-19 in patients receiving allogeneic stem cell transplantation for myeloid malignancy was altered by immunosuppressive therapy
|
Macková, Jana
|
|
|
130 |
C |
p.
|
article
|
Journal description